Aimmune Therapeutics

(NASDAQ: AIMT)
Healthcare  |  Biotechnology
25.00 0.785 3.24%
Stock Price | Oct. 15, 2019, 4 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 24.21
52 Week Low: 16.95
52 Week High: 36.12
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 09/07/2016

3 years ago

Premium Stock Watchlist 09/04/2015

4 years ago